Literature DB >> 15695790

Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging.

Timothy M Shoup1, David R Elmaleh, Ali A Bonab, Alan J Fischman.   

Abstract

UNLABELLED: This study describes the radiosynthesis and preliminary biologic evaluation of trans-9(RS)-(18)F-fluoro-3,4(RS,RS)-methyleneheptadecanoic acid ((18)F-FCPHA) as a new potential probe for assessing myocardial fatty acid metabolism by PET. This fatty acid, containing a cyclopropyl moiety in the beta,gamma-position, was designed to enter the myocardium by the same mechanism as natural fatty acids and to undergo partial metabolism before being trapped in the cell.
METHODS: (18)F-FCPHA and the beta-methyl analog 8(RS)-(18)F-fluoro-3(RS)-methylheptadecanoic acid ((18)F-FBMHA) were prepared from their corresponding mesylate precursors by nucleophilic substitution. The precursors used for labeling were fully characterized, and the data were consistent with the proposed structures. Biodistribution studies of each tracer were performed with Sprague-Dawley rats at 5 and 60 min after injection. Sequential imaging of a rhesus monkey injected with 222 MBq of (18)F-FCPHA was performed by use of a microPET camera.
RESULTS: At 5 and 60 min, heart uptake values measured as mean +/- SD percentage injected dose per gram (%ID/g) in rats for (18)F-FCPHA were 1.55 +/- 0.72 and 1.43 +/- 0.14, respectively. The heart-to-blood ratios at 5 and 60 min, an indication of target definition, were 25.8 and 20.4, respectively. The heart-to-lung ratios at 5 and 60 min were 3.3 and 4.6, respectively. Bone accumulation (%ID/g), an indication of defluorination, was 0.16 +/- 0.03 at 5 min and increased to 0.70 +/- 0.39 at 60 min. The heart-to-blood ratio obtained with (18)F-FBMHA was 2.6 at 5 min and did not change significantly at 60 min. Imaging of the monkey heart after injection of (18)F-FCPHA showed an initial spike of activity corresponding to blood flow followed by a plateau at 10 min.
CONCLUSION: The cyclopropyl moiety in (18)F-FCPHA does have a significant influence on heart accumulation, as suggested by the high heart-to-blood ratio and the fast blood clearance in rats. These results, along with the remarkable quality of the PET images, indicate the potential of this new class of labeled fatty acids for use in studying heart disease by PET.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695790

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.

Authors:  Zhude Tu; Shihong Li; Terry L Sharp; Pilar Herrero; Carmen S Dence; Robert J Gropler; Robert H Mach
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

Review 2.  Synthesis and validation of fatty acid analogs radiolabeled by nonisotopic substitution.

Authors:  William C Eckelman; John W Babich
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 3.  SPECT and PET in ischemic heart failure.

Authors:  George Angelidis; Gregory Giamouzis; Georgios Karagiannis; Javed Butler; Ioannis Tsougos; Varvara Valotassiou; George Giannakoulas; Nikolaos Dimakopoulos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis; Panagiotis Georgoulias
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

4.  Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers.

Authors:  Manuel Cerqueira; James Case; Jamshid Maddahi
Journal:  J Nucl Cardiol       Date:  2015-07-01       Impact factor: 5.952

5.  Effects of burn injury, cold stress and cutaneous wound injury on the morphology and energy metabolism of murine brown adipose tissue (BAT) in vivo.

Authors:  Edward A Carter; Ali A Bonab; Victoria Hamrahi; Justin Pitman; Daniel Winter; Lacey J Macintosh; Erika M Cyr; Kasie Paul; John Yerxa; Walter Jung; Ronald G Tompkins; Alan J Fischman
Journal:  Life Sci       Date:  2011-05-04       Impact factor: 5.037

6.  Sex difference in cardiac metabolism in nonischemic heart failure: Insight for prognostic value of altered cardiac metabolism.

Authors:  Hyung-Jun Im; Gi Jeong Cheon
Journal:  J Nucl Cardiol       Date:  2016-04-06       Impact factor: 5.952

Review 7.  Cardiac molecular imaging to track left ventricular remodeling in heart failure.

Authors:  Jamshid Shirani; Amitoj Singh; Sahil Agrawal; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2016-08-01       Impact factor: 5.952

Review 8.  Imaging of myocardial fatty acid oxidation.

Authors:  Kieren J Mather; Timothy R DeGrado
Journal:  Biochim Biophys Acta       Date:  2016-02-27

Review 9.  Radionuclide imaging of myocardial metabolism.

Authors:  Linda R Peterson; Robert J Gropler
Journal:  Circ Cardiovasc Imaging       Date:  2010-03       Impact factor: 7.792

Review 10.  Metabolic imaging using PET.

Authors:  Takashi Kudo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.